Pages that link to "Q34507941"
Jump to navigation
Jump to search
The following pages link to Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days (Q34507941):
Displaying 38 items.
- Comparison of Outcomes before and after Ohio's Law Mandating Use of the FDA-Approved Protocol for Medication Abortion: A Retrospective Cohort Study (Q28553778) (← links)
- Timing of pain and bleeding after mifepristone-induced abortion (Q32140859) (← links)
- Self-assessment of eligibility for early medical abortion using m-Health to calculate gestational age in Cape Town, South Africa: a feasibility pilot study (Q33448254) (← links)
- Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost (Q33937135) (← links)
- Mifepristone: bioavailability, pharmacokinetics and use-effectiveness (Q34540819) (← links)
- Acceptability and safety profile of oral and sublingual misoprostol for uterine evacuation following early fetal demise (Q35040320) (← links)
- Prostaglandins for first-trimester termination (Q35217869) (← links)
- Perceptions and practices of illegal abortion among urban young adults in the Philippines: a qualitative study (Q35551095) (← links)
- Comparing the World Health Organization-versus China-recommended protocol for first-trimester medical abortion: a retrospective analysis (Q35885192) (← links)
- Medical abortion with mifepristone and home administration of misoprostol up to 63 days' gestation (Q36349222) (← links)
- Knowledge of medication abortion among adolescent medicine providers (Q36799888) (← links)
- Misoprostol for the termination of pregnancy up to 12 completed weeks of pregnancy (Q36981870) (← links)
- Is mifepristone 100mg an effective alternative to standard dose for medical abortion (Q37611187) (← links)
- Comparison of medical abortion follow-up with serum human chorionic gonadotropin testing and in-office assessment (Q37953089) (← links)
- Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial (Q39755734) (← links)
- Emergency contraception: the politics of post-coital contraception (Q40274510) (← links)
- WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion (Q40503298) (← links)
- Early pregnancy termination with vaginal misoprostol combined with loperamide and acetaminophen prophylaxis (Q40602317) (← links)
- Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy (Q42687190) (← links)
- Home administration of misoprostol for early medical abortion in India (Q43234266) (← links)
- Serum beta-human chorionic gonadotropin levels and endometrial thickness after medical abortion (Q43670382) (← links)
- Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion (Q43796258) (← links)
- Mifepristone followed on the same day by vaginal misoprostol for early abortion (Q43796262) (← links)
- Mifepristone abortion in minors (Q43880254) (← links)
- Users' perspectives on medical abortion in Finland (Q44071347) (← links)
- Mifepristone and vaginal misoprostol on the same day for abortion from 50 to 63 days' gestation (Q44202966) (← links)
- Present and potential uses of mifepristone in gynecology, obstetrics and other medical specialties (Q45248905) (← links)
- Gynaecological uses of a new class of steroids: the selective progesterone receptor modulators (Q46104100) (← links)
- Endometrial thickness and serum beta-hCG as predictors of the effectiveness of oral misoprostol in early pregnancy failure (Q46225700) (← links)
- The acceptability of home medical abortion to women in UK settings (Q46517558) (← links)
- Mifepristone 100 mg for early medical abortion (Q46596960) (← links)
- Home use of two doses of misoprostol after mifepristone for medical abortion: a pilot study in Sweden and France (Q46828541) (← links)
- First trimester abortion with mifepristone and three doses of sublingual misoprostol: a pilot study (Q46885784) (← links)
- Early abortion services in the United States: a provider survey (Q47988871) (← links)
- Normalizing the exceptional: incorporating the “abortion pill” into mainstream medicine (Q53388248) (← links)
- Analgesia during at-home use of misoprostol as part of a medical abortion regimen (Q73588735) (← links)
- Monitoring serum chorionic gonadotropin levels after mifepristone abortion (Q77451156) (← links)
- Simultaneous administration of mifepristone and misoprostol for early termination of pregnancy: a randomized controlled trial (Q83694388) (← links)